Many are also forgetting an impressive Phase 2 ovarian cancer trial and veterinary applications already utilized. Vet use will be limited for now but high value animals can, have and will be helped. Once the “sameness” of L and Direct gets promoted more then the Phase 1 Direct trial will be used to validate use of L in other indications as well and Direct will be moved forward quickly into patient accessibility as a safe treatment that is rapidly effective. Combo those 2 and watch out for the Triozzi et al discovered synergy. Best wishes.
Market Data 
Markets 
AI
